{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,30]],"date-time":"2026-08-30T07:14:39Z","timestamp":1788074079081,"version":"build-2784847793"},"reference-count":42,"publisher":"Oxford University Press (OUP)","license":[{"start":{"date-parts":[[2026,8,30]],"date-time":"2026-08-30T00:00:00Z","timestamp":1788048000000},"content-version":"am","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/100007405","name":"Danish Heart Foundation","doi-asserted-by":"publisher","award":["11-10-R87-B-A3628-22678"],"award-info":[{"award-number":["11-10-R87-B-A3628-22678"]}],"id":[{"id":"10.13039\/100007405","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Aims<\/jats:title>\n                    <jats:p>Interleukin-6 (IL-6) has been linked to major adverse cardiovascular events (MACE) in the general population. Among women with angina and no obstructive coronary artery disease (ANOCA), IL-6 has been associated with coronary microvascular dysfunction (CMD), a known driver of risk in this population. We aimed to investigate whether IL-6 identifies a cardiometabolic high-risk phenotype and predicts long-term cardiovascular outcomes in women with ANOCA, and whether its prognostic value is modified by CMD.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and results<\/jats:title>\n                    <jats:p>The iPOWER cohort included 1853 women with stable angina and &amp;lt;50% coronary stenosis at coronary angiography. Of these, 1636 had measures of plasma IL-6 at baseline. The primary outcome was a composite of cardiovascular death, myocardial infarction, revascularization, ischaemic stroke, and heart failure. Associations with outcomes were assessed using Cox proportional hazards models adjusted for age and cardiovascular risk factors, with prespecified subgroup analyses, including assessment of potential effect modification by CMD assessed by TTE-derived coronary flow velocity reserve (CFVR). Higher IL-6 was associated with a cardiometabolically shifted phenotype characterized by adiposity, diabetes, a high triglyceride\u2013high-density lipoprotein-cholesterol lipid profile, and reduced CFVR. During a median follow-up of 10.8 years, 250 women (15.3%) experienced MACE. IL-6 predicted MACE [hazard ratios (HR) 1.23, 95% confidence interval 1.07\u20131.41]. The association did not vary by CMD status (HR 1.25 vs. 1.16).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>IL-6 identifies an inflammation-driven cardiometabolic high-risk phenotype in women with ANOCA and independently predicts MACE. The prognostic value of IL-6 does not depend on CMD, underscoring IL-6 as a clinically relevant marker of long-term cardiovascular risk.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/eurjpc\/zwag398","type":"journal-article","created":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T11:23:59Z","timestamp":1785151439000},"source":"Crossref","is-referenced-by-count":0,"title":["Women with angina and no obstructive coronary artery disease: IL-6 identifies a cardiometabolic high-risk phenotype and predicts cardiovascular events"],"prefix":"10.1093","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-7411-8430","authenticated-orcid":false,"given":"Rasmus","family":"Haahr","sequence":"first","affiliation":[{"name":"Department of Cardiology, Copenhagen University Hospital - Bispebjerg and Frederiksberg , Bispebjerg Bakke 23, 2400 K\u00f8benhavn NV, Copenhagen ,","place":["Denmark"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura Amalie","family":"Rytoft","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Copenhagen University Hospital - Bispebjerg and Frederiksberg , Bispebjerg Bakke 23, 2400 K\u00f8benhavn NV, Copenhagen ,","place":["Denmark"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naja Dam","family":"Mygind","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Copenhagen University Hospital - Bispebjerg and Frederiksberg , Bispebjerg Bakke 23, 2400 K\u00f8benhavn NV, Copenhagen ,","place":["Denmark"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Therese Lucia Friis","family":"Holmager","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Copenhagen University Hospital - Bispebjerg and Frederiksberg , Bispebjerg Bakke 23, 2400 K\u00f8benhavn NV, Copenhagen ,","place":["Denmark"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter Dall","family":"Mark","sequence":"additional","affiliation":[{"name":"Department of Clinical Physiology and Nuclear Medicine, Copenhagen University Hospital - Bispebjerg and Frederiksberg , Copenhagen ,","place":["Denmark"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rasmus Sejersten","family":"Ripa","sequence":"additional","affiliation":[{"name":"Department of Clinical Physiology and Nuclear Medicine, Copenhagen University Hospital - Bispebjerg and Frederiksberg , Copenhagen ,","place":["Denmark"]},{"name":"Department of Clinical Medicine, University of Copenhagen , Copenhagen ,","place":["Denmark"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva Irene Bossano","family":"Prescott","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Copenhagen University Hospital - Bispebjerg and Frederiksberg , Bispebjerg Bakke 23, 2400 K\u00f8benhavn NV, Copenhagen ,","place":["Denmark"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,8,30]]},"reference":[{"key":"2026083002161678700_zwag398-B1","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1093\/eurheartj\/ehr331","article-title":"Stable angina pectoris with no obstructive coronary artery disease is associated with increased risks of major adverse cardiovascular events","volume":"33","author":"Jespersen","year":"2012","journal-title":"Eur Heart J"},{"key":"2026083002161678700_zwag398-B2","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/S0002-9149(01)01424-2","article-title":"Detailed angiographic analysis of women with suspected ischemic chest pain (pilot phase data from the NHLBI-sponsored Women\u2019s Ischemia Syndrome Evaluation [WISE] study angiographic core laboratory)","volume":"87","author":"Sharaf","year":"2001","journal-title":"Am J Cardiol"},{"key":"2026083002161678700_zwag398-B3","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1161\/CIRCRESAHA.121.319892","article-title":"Coronary arterial function and disease in women with no obstructive coronary arteries","volume":"130","author":"Reynolds","year":"2022","journal-title":"Circ Res"},{"key":"2026083002161678700_zwag398-B4","doi-asserted-by":"crossref","first-page":"2385","DOI":"10.1016\/S0140-6736(21)00684-X","article-title":"The Lancet women and cardiovascular disease Commission: reducing the global burden by 2030","volume":"397","author":"Vogel","year":"2021","journal-title":"Lancet"},{"key":"2026083002161678700_zwag398-B5","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.annepidem.2021.07.012","article-title":"Cardiovascular damage phenotypes and all-cause and CVD mortality in older adults","volume":"63","author":"Miller","year":"2021","journal-title":"Ann Epidemiol"},{"key":"2026083002161678700_zwag398-B6","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1038\/s44161-023-00391-y","article-title":"Cardiometabolic and renal phenotypes and transitions in the United States population","volume":"3","author":"Lhoste","year":"2023","journal-title":"Nat Cardiovasc Res"},{"key":"2026083002161678700_zwag398-B7","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s40842-025-00227-7","article-title":"Cluster analysis reveals distinct inflammatory phenotypes in cardiometabolic disease","volume":"11","author":"Bianchi","year":"2025","journal-title":"Cardiovasc Diabetol Endocrinol Rep"},{"key":"2026083002161678700_zwag398-B8","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/j.jcmg.2012.12.011","article-title":"Inflammation and microvascular dysfunction in cardiac syndrome X patients without conventional risk factors for coronary artery disease","volume":"6","author":"Recio-Mayoral","year":"2013","journal-title":"JACC Cardiovasc Imaging"},{"key":"2026083002161678700_zwag398-B9","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.115.003064","article-title":"Coronary microvascular function and cardiovascular risk factors in women with angina pectoris and no obstructive coronary artery disease: the iPOWER study","volume":"5","author":"Mygind","year":"2016","journal-title":"J Am Heart Assoc"},{"key":"2026083002161678700_zwag398-B10","doi-asserted-by":"crossref","first-page":"107239","DOI":"10.1016\/j.vph.2023.107239","article-title":"Pathophysiology of coronary microvascular dysfunction","volume":"153","author":"Crea","year":"2023","journal-title":"Vascul Pharmacol"},{"key":"2026083002161678700_zwag398-B11","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1093\/eurheartj\/eht513","article-title":"Coronary microvascular dysfunction: an update","volume":"35","author":"Crea","year":"2014","journal-title":"Eur Heart J"},{"key":"2026083002161678700_zwag398-B12","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.1038\/s41591-019-0675-0","article-title":"Chronic inflammation in the etiology of disease across the life span","volume":"25","author":"Furman","year":"2019","journal-title":"Nat Med"},{"key":"2026083002161678700_zwag398-B13","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/s11897-025-00710-3","article-title":"Inflammatory biomarkers in heart failure: clinical perspectives on hsCRP, IL-6 and emerging candidates","volume":"22","author":"Kurt","year":"2025","journal-title":"Curr Heart Fail Rep"},{"key":"2026083002161678700_zwag398-B14","doi-asserted-by":"crossref","first-page":"101063","DOI":"10.1016\/j.jacadv.2024.101063","article-title":"Interleukin-6 and cardiovascular events in healthy adults","volume":"3","author":"Khan","year":"2024","journal-title":"JACC Adv"},{"key":"2026083002161678700_zwag398-B15","doi-asserted-by":"crossref","DOI":"10.1111\/jcmm.70028","article-title":"Interleukin-6 positively correlates with cardiovascular disease predictor algorithms and biomarker in rheumatoid arthritis patients","volume":"28","author":"Roghani","year":"2024","journal-title":"J Cell Mol Med"},{"key":"2026083002161678700_zwag398-B16","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1007\/s11883-024-01259-7","article-title":"IL-6 and cardiovascular risk: a narrative review","volume":"27","author":"Mehta","year":"2025","journal-title":"Curr Atheroscler Rep"},{"key":"2026083002161678700_zwag398-B17","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCGEN.119.002872","article-title":"Interleukin-6 signaling effects on ischemic stroke and other cardiovascular outcomes: a Mendelian randomization study","volume":"13","author":"Georgakis","year":"2020","journal-title":"Circ Genomic Precis Med"},{"key":"2026083002161678700_zwag398-B18","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1161\/CIRCRESAHA.121.319077","article-title":"Interleukin-6 signaling and anti-interleukin-6 therapeutics in cardiovascular disease","volume":"128","author":"Ridker","year":"2021","journal-title":"Circ Res"},{"key":"2026083002161678700_zwag398-B19","doi-asserted-by":"crossref","first-page":"2328","DOI":"10.1038\/s41591-024-03043-1","article-title":"IL-6 inhibition with clazakizumab in patients receiving maintenance dialysis: a randomized phase 2b trial","volume":"30","author":"Chertow","year":"2024","journal-title":"Nat Med"},{"key":"2026083002161678700_zwag398-B20","author":"Novo Nordisk A. S"},{"key":"2026083002161678700_zwag398-B21","author":"Novo Nordisk A. S"},{"key":"2026083002161678700_zwag398-B22","doi-asserted-by":"crossref","first-page":"100264","DOI":"10.1016\/j.jacadv.2023.100264","article-title":"Biomarkers and coronary microvascular dysfunction in women with angina and no obstructive coronary artery disease","volume":"2","author":"Prescott","year":"2023","journal-title":"JACC Adv"},{"key":"2026083002161678700_zwag398-B23","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.ahj.2014.01.003","article-title":"Improving diagnosis and treatment of women with angina pectoris and microvascular disease: the iPOWER study design and rationale","volume":"167","author":"Prescott","year":"2014","journal-title":"Am Heart J"},{"key":"2026083002161678700_zwag398-B24","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.ijcard.2016.11.004","article-title":"Transthoracic Doppler echocardiography compared with positron emission tomography for assessment of coronary microvascular dysfunction: the iPOWER study","volume":"228","author":"Michelsen","year":"2017","journal-title":"Int J Cardiol"},{"key":"2026083002161678700_zwag398-B25","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/j.echo.2016.02.011","article-title":"Coronary flow velocity reserve assessed by transthoracic Doppler: the iPOWER study: factors influencing feasibility and quality","volume":"29","author":"Michelsen","year":"2016","journal-title":"J Am Soc Echocardiogr"},{"key":"2026083002161678700_zwag398-B26","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1093\/eurheartj\/ehaa944","article-title":"Coronary flow velocity reserve predicts adverse prognosis in women with angina and no obstructive coronary artery disease: results from the iPOWER study","volume":"42","author":"Schroder","year":"2021","journal-title":"Eur Heart J"},{"key":"2026083002161678700_zwag398-B27","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/s12947-016-0066-3","article-title":"Coronary flow velocity reserve by echocardiography: feasibility, reproducibility and agreement with PET in overweight and obese patients with stable and revascularized coronary artery disease","volume":"14","author":"Olsen","year":"2015","journal-title":"Cardiovasc Ultrasound"},{"key":"2026083002161678700_zwag398-B28","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1093\/eurheartj\/ehac001","article-title":"Coronary flow reserve: a versatile tool for interrogating pathophysiology, and a reliable marker of cardiovascular outcomes and mortality","volume":"43","author":"Taqueti","year":"2022","journal-title":"Eur Heart J"},{"key":"2026083002161678700_zwag398-B29"},{"key":"2026083002161678700_zwag398-B30","doi-asserted-by":"crossref","first-page":"e0177684","DOI":"10.1371\/journal.pone.0177684","article-title":"Inflammatory biomarkers as predictors of heart failure in women without obstructive coronary artery disease: a report from the NHLBI-sponsored Women\u2019s Ischemia Syndrome Evaluation (WISE). Bugiardini R, editor","volume":"12","author":"AlBadri","year":"2017","journal-title":"PLoS One"},{"key":"2026083002161678700_zwag398-B31","doi-asserted-by":"crossref","first-page":"3415","DOI":"10.1093\/eurheartj\/ehae177","article-title":"2024 ESC guidelines for the management of chronic coronary syndromes","volume":"45","author":"Vrints","year":"2024","journal-title":"Eur Heart J"},{"key":"2026083002161678700_zwag398-B32","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1161\/01.CIR.101.15.1767","article-title":"Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men","volume":"101","author":"Ridker","year":"2000","journal-title":"Circulation"},{"key":"2026083002161678700_zwag398-B33","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.jacbts.2022.08.009","article-title":"Coronary flow reserve, inflammation, and myocardial strain","volume":"8","author":"Taqueti","year":"2023","journal-title":"JACC Basic Transl Sci"},{"key":"2026083002161678700_zwag398-B34","doi-asserted-by":"crossref","first-page":"13471","DOI":"10.3390\/ijms222413471","article-title":"Inflammation in coronary microvascular dysfunction","volume":"22","author":"Sagris","year":"2021","journal-title":"Int J Mol Sci"},{"key":"2026083002161678700_zwag398-B35","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1159\/000084844","article-title":"IL-6 and its circadian secretion in humans","volume":"12","author":"Vgontzas","year":"2005","journal-title":"Neuroimmunomodulation"},{"key":"2026083002161678700_zwag398-B36","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1111\/j.1469-7793.2000.00237.x","article-title":"Production of interleukin-6 in contracting human skeletal muscles can account for the exercise-induced increase in plasma interleukin-6","volume":"529","author":"Steensberg","year":"2000","journal-title":"J Physiol"},{"key":"2026083002161678700_zwag398-B37","doi-asserted-by":"crossref","first-page":"117461","DOI":"10.1016\/j.atherosclerosis.2024.117461","article-title":"Comparison of interleukin-6 and high-sensitivity C-reactive protein for cardiovascular risk assessment: findings from the MESA study","volume":"390","author":"Ferreira","year":"2024","journal-title":"Atherosclerosis"},{"key":"2026083002161678700_zwag398-B38","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1016\/S0735-1097(99)00342-3","article-title":"Validation of a new noninvasive method (contrast-enhanced transthoracic second harmonic echo Doppler) for the evaluation of coronary flow reserve","volume":"34","author":"Caiati","year":"1999","journal-title":"J Am Coll Cardiol"},{"key":"2026083002161678700_zwag398-B39","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.freeradbiomed.2018.03.050","article-title":"Activation of the monocytic \u03b17 nicotinic acetylcholine receptor modulates oxidative stress and inflammation-associated development of coronary artery spasm via a p38 MAP-kinase signaling-dependent pathway","volume":"120","author":"Hung","year":"2018","journal-title":"Free Radic Biol Med"},{"key":"2026083002161678700_zwag398-B40","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.3390\/ph18091384","article-title":"Lipoprotein(a)\/CD36 interaction drives IL-6\/RhoA-GTP signaling and miRNA epigenetic regulation in coronary artery spasm","volume":"18","author":"Lin","year":"2025","journal-title":"Pharmaceuticals"},{"key":"2026083002161678700_zwag398-B41","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2016-012832","article-title":"Positive predictive value of cardiovascular diagnoses in the Danish National Patient Registry: a validation study","volume":"6","author":"Sundb\u00f8ll","year":"2016","journal-title":"BMJ Open"},{"key":"2026083002161678700_zwag398-B42","doi-asserted-by":"publisher","DOI":"10.1093\/ehjqcco\/qcag055","article-title":"Validating national registry data for randomized trials: comparison of registry-derived cardiovascular events with and without adjudication in the BETAMI-DANBLOCK trial","author":"Holmager","year":"2026","journal-title":"Eur Heart J Qual Care Clin Outcomes"}],"container-title":["European Journal of Preventive Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/eurjpc\/advance-article-pdf\/doi\/10.1093\/eurjpc\/zwag398\/70699308\/zwag398.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eurjpc\/advance-article-pdf\/doi\/10.1093\/eurjpc\/zwag398\/70699308\/zwag398.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,30]],"date-time":"2026-08-30T06:16:27Z","timestamp":1788070587000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eurjpc\/advance-article\/doi\/10.1093\/eurjpc\/zwag398\/8765337"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,30]]},"references-count":42,"URL":"https:\/\/doi.org\/10.1093\/eurjpc\/zwag398","relation":{},"ISSN":["2047-4873","2047-4881"],"issn-type":[{"value":"2047-4873","type":"print"},{"value":"2047-4881","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,30]]},"article-number":"zwag398"}}